Furosemide (Lasix) Dosing in Adults
For adults with edema or heart failure, start furosemide at 20-40 mg orally once or twice daily, titrating upward by 20-40 mg increments every 3-5 days until adequate diuresis is achieved, with usual maximum doses of 160-600 mg/day depending on indication and renal function. 1, 2
Oral Dosing for Edema
Initial Dosing
- Start with 20-40 mg once or twice daily for most patients with fluid retention 1, 2
- Single morning dosing maximizes compliance 1
- Even 20 mg daily produces significant diuretic and natriuretic effects in heart failure patients 3
Dose Titration
- Increase by 20-40 mg increments every 3-5 days if weight loss and natriuresis are inadequate 1
- Target weight loss of 0.5 kg/day in patients without edema and 1 kg/day in patients with edema 1
- Continue titration until clinical evidence of fluid retention resolves 1
Maximum Doses
- Standard maximum: 160-240 mg/day for most heart failure patients 1
- Absolute maximum: 600 mg/day in refractory cases 1, 2
- Higher doses (up to 720 mg/day orally) have been used safely in resistant edematous states 4
Intravenous Dosing
Acute Edema
- Initial IV dose: 20-40 mg given slowly over 1-2 minutes 2
- If inadequate response after 2 hours, may increase by 20 mg increments 2
- Maximum rate for IV infusion: 4 mg/min to prevent ototoxicity 2
Acute Pulmonary Edema
- Initial dose: 40 mg IV slowly over 1-2 minutes 2
- If inadequate response within 1 hour, increase to 80 mg IV slowly 2
High-Dose IV Therapy
- For severe heart failure: 40 mg IV load, then 10-40 mg/hour continuous infusion 1
- Total furosemide should remain <100 mg in first 6 hours and <240 mg in first 24 hours 1
- Must be diluted in alkaline solution (pH >5.5) and infused at ≤4 mg/min 2
Adjustments for Renal Impairment
Chronic Kidney Disease
- In patients with creatinine clearance <20 mL/min, single IV doses of 120-160 mg reach maximal response 5
- No need for single doses exceeding 160 mg IV in severe renal insufficiency 5
- Oral doses may need to be higher (up to 720 mg/day) due to reduced bioavailability 4
Cirrhosis with Ascites
- Start with spironolactone 100 mg/day alone for first episode of moderate ascites 1
- If inadequate response, add furosemide starting at 40 mg/day 1
- Increase both drugs simultaneously maintaining 100:40 mg ratio (spironolactone:furosemide) every 3-5 days 1
- Usual maximum: spironolactone 400 mg/day with furosemide 160 mg/day 1
Combination Therapy
Sequential Nephron Blockade
- For diuretic resistance, add metolazone 2.5-10 mg once daily or hydrochlorothiazide 25-100 mg once or twice daily to loop diuretic 1
- Alternatively, chlorothiazide 500-1000 mg IV can be combined with loop diuretics 1
- Monitor electrolytes closely as combination therapy markedly enhances risk of depletion 1
Monitoring Requirements
Initial Phase
- Frequent clinical and biochemical monitoring during first weeks of treatment, particularly on first presentation 1
- Measure serum creatinine, sodium, and potassium shortly after initiating therapy and periodically thereafter 1
Ongoing Monitoring
- Daily weights with patient-directed dose adjustments based on specified weight range 1
- Assess for signs of volume depletion (hypotension, azotemia) versus persistent congestion 1
Critical Safety Considerations
Contraindications and Cautions
- Discontinue if severe hyponatremia (<125 mmol/L), acute kidney injury, worsening hepatic encephalopathy, or incapacitating muscle cramps develop 1
- Stop furosemide if severe hypokalemia (<3 mmol/L) occurs 1
- Avoid in patients with systolic blood pressure <90 mmHg 1
- Use cautiously with loop-inhibiting diuretics due to increased ototoxicity risk 1
Electrolyte Management
- Concomitant ACE inhibitors or aldosterone antagonists can prevent potassium depletion and often eliminate need for long-term potassium supplementation 1
- When ACE inhibitors/aldosterone antagonists are prescribed, long-term oral potassium supplementation may be deleterious 1
Renal Considerations
- IV furosemide 80 mg can cause acute reduction in renal perfusion and azotemia in cirrhosis patients 1
- Recent evidence suggests furosemide may exacerbate renal damage following ischemic injury and should be used with caution in perioperative AKI 6